Replies to post #20216 on Radient Pharmaceuticals Corporation fka RXPC

[dcspka]

Ahh, Andrea Howard-Small, a former executive with RXPC in charge of Product Development, is now quietly paving the way behind-the-scenes for the re emergence of DR-70 in Asian countries where SRL,Inc & Uni-Pharma have licensing agreements with RXPC. Look for a huge marketing effort once the company changes hands.

Andrea Howard-Small
President
International Biotechnology Solutions

July 2011 – Present (2 years 9 months) Greater San Diego Area

International Biotechnology Solutions creates customized, cost-effective commercialization solutions for viable yet abandoned biopharma products. Based on our understanding that the paradigm by which biotechnology and pharmaceutical products reach the market has fundamentally changed, we explore new avenues to bring healthcare products to market in regions where there are unique needs. In particular, developing commercialization solutions to meet the needs of the healthcare market in the Asia-Pacific region can be more cost effective and may benefit a larger population.

Please note the sentence: " International Biotechnology Solutions creates customized, cost-effective commercialization solutions for viable yet abandoned biopharma products....". Hmm- does Onko Sure ring a bell, folks? Look for its re emergence Very Soon.

[lakeshore555]

What patent? the patent filed in 2009, rejected in 2012, re-submitted as an RCE in 2013?

That's perfect timing? the active patent expires in about two months and the RCE could take years. The timing seems less than perfect to me.